Alexandra Hendzel

Alexandra Hendzel, PharmD, MPA, RPh, currently serves as the Director of Regulatory Affairs, Oncology at Stemline Therapeutics since October 2022. Prior to this role, Alexandra held various positions at Novartis from July 2015 to September 2022, including Senior Global Program Regulatory Manager for both Oncology and Hematology. Alexandra also worked as a Global Program Regulatory Manager in Hematology and was a Post-Doctoral Fellow at Rutgers University specializing in Cardiovascular-Metabolic. While at Rutgers University, Alexandra contributed as an Adjunct Faculty member from July 2015 to May 2017. Early experience includes serving as a Pharmacy Intern at Walgreens and as a Certified Pharmacy Technician at CVS Caremark Corporation. Alexandra obtained both a Doctor of Pharmacy and a Master of Public Administration from Drake University between 2009 and 2015, and attended Neuqua Valley High School from 2005 to 2009.